Recro Pharma, Inc.·4

Dec 28, 8:18 PM ET

SCP Vitalife Partners II LP 4

4 · Recro Pharma, Inc. · Filed Dec 28, 2020

Insider Transaction Report

Form 4
Period: 2020-12-22
Transactions
  • Sale

    Common Stock

    2020-12-22$3.17/sh56,375$178,7092,097,938 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.1001 to $3.3058, inclusive. The reporting person undertakes to provide Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT